aluates Reports

$ 0.0

Automative

Global PD-L1 and PIK3CA Testing Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-8D9429

Global PD L1 and PIK3CA Testing Market Insights and Forecast to 2028

BUY CHAPTERS

Global PD-L1 and PIK3CA Testing Market Research Report 2024

Code: QYRE-Auto-8D9429

Report

March 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Roche

Qiagen NV

EntroGen

Amoy Diagnostics

ACCB Biotech

PD-L1 and PIK3CA Testing Market Size

Testing market was valued at US$ 521.8 million in 2023 and is anticipated to reach US$ 1964.3 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.

PD-L1 and PIK3CA Testing Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.

PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.

PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.

The global PD-L1 and PIK3CA

The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.

PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.

North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.

Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.

This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.

Report Scope

The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PD-L1 and PIK3CA Testing Market Report

Report Metric	Details
Report Name	PD-L1 and PIK3CA Testing Market
Accounted market size in 2023	US$ 521.8 million
Forecasted market size in 2030	US$ 1964.3 million
CAGR	20.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	PD-L1 Testing PIK3CA Testing
Segment by Application	Hospital Diagnostic Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PD-L1 and PIK3CA Testing Market growing?

Ans: The PD-L1 and PIK3CA Testing Market witnessing a CAGR of 20.6% during the forecast period 2024-2030.

What is the PD-L1 and PIK3CA Testing Market size in 2030?

Ans: The PD-L1 and PIK3CA Testing Market size in 2030 will be US$ 1964.3 million.

What is the PD-L1 and PIK3CA Testing Market share by type?

Ans: PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.

What is the PD-L1 and PIK3CA Testing Market share by region?

Ans: North America is the largest consumption place, with a market share nearly 57% .

Who are the main players in the PD-L1 and PIK3CA Testing Market report?

Ans: The main players in the PD-L1 and PIK3CA Testing Market are Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech

What are the Application segmentation covered in the PD-L1 and PIK3CA Testing Market report?

Ans: The Applications covered in the PD-L1 and PIK3CA Testing Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the PD-L1 and PIK3CA Testing Market report?

Ans: The Types covered in the PD-L1 and PIK3CA Testing Market report are PD-L1 Testing, PIK3CA Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PD-L1 Testing

1.2.3 PIK3CA Testing

1.3 Market by Application

1.3.1 Global PD-L1 and PIK3CA Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global PD-L1 and PIK3CA Testing Market Perspective (2019-2030)

2.2 PD-L1 and PIK3CA Testing Growth Trends by Region

2.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2019-2024)

2.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2025-2030)

2.3 PD-L1 and PIK3CA Testing Market Dynamics

2.3.1 PD-L1 and PIK3CA Testing Industry Trends

2.3.2 PD-L1 and PIK3CA Testing Market Drivers

2.3.3 PD-L1 and PIK3CA Testing Market Challenges

2.3.4 PD-L1 and PIK3CA Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue

3.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2019-2024)

3.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2019-2024)

3.2 Global PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by PD-L1 and PIK3CA Testing Revenue

3.4 Global PD-L1 and PIK3CA Testing Market Concentration Ratio

3.4.1 Global PD-L1 and PIK3CA Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-L1 and PIK3CA Testing Revenue in 2023

3.5 PD-L1 and PIK3CA Testing Key Players Head office and Area Served

3.6 Key Players PD-L1 and PIK3CA Testing Product Solution and Service

3.7 Date of Enter into PD-L1 and PIK3CA Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 PD-L1 and PIK3CA Testing Breakdown Data by Type

4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2019-2024)

4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2025-2030)

5 PD-L1 and PIK3CA Testing Breakdown Data by Application

5.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2019-2024)

5.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America PD-L1 and PIK3CA Testing Market Size (2019-2030)

6.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)

6.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PD-L1 and PIK3CA Testing Market Size (2019-2030)

7.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)

7.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2019-2030)

8.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PD-L1 and PIK3CA Testing Market Size (2019-2030)

9.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)

9.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2019-2030)

10.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Detail

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction

11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.1.5 Agilent Technologies Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche PD-L1 and PIK3CA Testing Introduction

11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.2.5 Roche Recent Development

11.3 QIAGEN

11.3.1 QIAGEN Company Detail

11.3.2 QIAGEN Business Overview

11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction

11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.3.5 QIAGEN Recent Development

11.4 EntroGen

11.4.1 EntroGen Company Detail

11.4.2 EntroGen Business Overview

11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction

11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.4.5 EntroGen Recent Development

11.5 Amoy Diagnostics

11.5.1 Amoy Diagnostics Company Detail

11.5.2 Amoy Diagnostics Business Overview

11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction

11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.5.5 Amoy Diagnostics Recent Development

11.6 ACCB Biotech

11.6.1 ACCB Biotech Company Detail

11.6.2 ACCB Biotech Business Overview

11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction

11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)

11.6.5 ACCB Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies

Roche

Qiagen NV

EntroGen

Amoy Diagnostics

ACCB Biotech

List of Tables

Table 1. Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PD-L1 Testing

Table 3. Key Players of PIK3CA Testing

Table 4. Global PD-L1 and PIK3CA Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global PD-L1 and PIK3CA Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global PD-L1 and PIK3CA Testing Market Share by Region (2019-2024)

Table 8. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global PD-L1 and PIK3CA Testing Market Share by Region (2025-2030)

Table 10. PD-L1 and PIK3CA Testing Market Trends

Table 11. PD-L1 and PIK3CA Testing Market Drivers

Table 12. PD-L1 and PIK3CA Testing Market Challenges

Table 13. PD-L1 and PIK3CA Testing Market Restraints

Table 14. Global PD-L1 and PIK3CA Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global PD-L1 and PIK3CA Testing Market Share by Players (2019-2024)

Table 16. Global Top PD-L1 and PIK3CA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing as of 2023)

Table 17. Ranking of Global Top PD-L1 and PIK3CA Testing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by PD-L1 and PIK3CA Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players PD-L1 and PIK3CA Testing Product Solution and Service

Table 21. Date of Enter into PD-L1 and PIK3CA Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global PD-L1 and PIK3CA Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2019-2024)

Table 25. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2025-2030)

Table 27. Global PD-L1 and PIK3CA Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2019-2024)

Table 29. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2025-2030)

Table 31. North America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Agilent Technologies Company Detail

Table 47. Agilent Technologies Business Overview

Table 48. Agilent Technologies PD-L1 and PIK3CA Testing Product

Table 49. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 50. Agilent Technologies Recent Development

Table 51. Roche Company Detail

Table 52. Roche Business Overview

Table 53. Roche PD-L1 and PIK3CA Testing Product

Table 54. Roche Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 55. Roche Recent Development

Table 56. QIAGEN Company Detail

Table 57. QIAGEN Business Overview

Table 58. QIAGEN PD-L1 and PIK3CA Testing Product

Table 59. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 60. QIAGEN Recent Development

Table 61. EntroGen Company Detail

Table 62. EntroGen Business Overview

Table 63. EntroGen PD-L1 and PIK3CA Testing Product

Table 64. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 65. EntroGen Recent Development

Table 66. Amoy Diagnostics Company Detail

Table 67. Amoy Diagnostics Business Overview

Table 68. Amoy Diagnostics PD-L1 and PIK3CA Testing Product

Table 69. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 70. Amoy Diagnostics Recent Development

Table 71. ACCB Biotech Company Detail

Table 72. ACCB Biotech Business Overview

Table 73. ACCB Biotech PD-L1 and PIK3CA Testing Product

Table 74. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)

Table 75. ACCB Biotech Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global PD-L1 and PIK3CA Testing Market Share by Type: 2023 VS 2030

Figure 3. PD-L1 Testing Features

Figure 4. PIK3CA Testing Features

Figure 5. Global PD-L1 and PIK3CA Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global PD-L1 and PIK3CA Testing Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Diagnostic Center Case Studies

Figure 9. Others Case Studies

Figure 10. PD-L1 and PIK3CA Testing Report Years Considered

Figure 11. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global PD-L1 and PIK3CA Testing Market Share by Region: 2023 VS 2030

Figure 14. Global PD-L1 and PIK3CA Testing Market Share by Players in 2023

Figure 15. Global Top PD-L1 and PIK3CA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by PD-L1 and PIK3CA Testing Revenue in 2023

Figure 17. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)

Figure 19. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)

Figure 23. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Region (2019-2030)

Figure 31. China PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)

Figure 39. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)

Figure 43. Turkey PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 46. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 47. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 48. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 49. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 50. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions